Fortress Biotech’s Majority-Controlled Subsidiary, Journey Medical Corporation, Receives FDA Approval for Emrosi™ for Rosacea Treatment
Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosiâ„¢ ...
Reading Eagle8h
Reflections – Old folks are thin-skinned
Too much sun frying your face over the decades also triggers rosacea in your latter years. Rosacea causes flushing and ...
dermatologyadvisor13h
Emrosi Approved to Treat Inflammatory Lesions of Rosacea
The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of rosacea in adults.
FDA approves Journey Medical’s rosacea treatment Emrosi
Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.
pharmaphorum20h
Journey slips on FDA approval of rosacea therapy
Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...